Safety, Ethics and Regulations [electronic resource] / edited by Phuc Van Pham, Achim Rosemann.

Інтелектуальна відповідальність: Вид матеріалу: Текст Серія: Stem Cells in Clinical ApplicationsПублікація: Cham : Springer International Publishing : Imprint: Springer, 2017Видання: 1st ed. 2017Опис: XIII, 327 p. 6 illus., 5 illus. in color. online resourceТип вмісту:
  • text
Тип засобу:
  • computer
Тип носія:
  • online resource
ISBN:
  • 9783319591650
Тематика(и): Додаткові фізичні формати: Printed edition:: Немає назви; Printed edition:: Немає назви; Printed edition:: Немає назвиДесяткова класифікація Дьюї:
  • 571.6 23
Класифікація Бібліотеки Конгресу:
  • QH588.S83
Електронне місцезнаходження та доступ:
Вміст:
Part  I. Safety -- Chapter 1: The safety of allogeneic stem cell transplantation -- Chapter 2: Induced Pluripotent Stem Cell Therapy and Safety Concerns in Age-related Chronic Neurodegenerative Diseases -- Chapter 3: IClinical safety and applications of stem cell gene therapy -- Chapter 4:  The safety of non-expanded multipotential stromal cell therapies -- Part  II: Ethics and Regulations -- Chapter 5: A Normative Case for the Patentability of Human Embryonic Stem Cell Technologies -- Chapter 6. Ethical Considerations in Stem Cell Research on Neurologic and Orthopedic Conditions -- Chapter 7. New Regulatory Pathways for Stem Cell-Based Therapies: Comparison and Critique of Potential Models -- Chapter 8: Travelling cells – Harmonised European Regualtion and the BAMI stem cell trial -- Chapter 9: Oversight and Evidence in Stem Cell Innovation: An Examination of International Guidelines -- Chapter 10: The regulation of clinical stem cell research in China -- Chapter 11: Gov erning Stem Cell Therapies in India -- Chapter 12: Patenting human embryonic stem cells in the European Union context: an updated analysis of a complex issue -- Chapter 13: The regulatory situation for clinical stem cell research in China -- Chapter 14: Contested Tissues: the donation of oocytes and embryos in the IVF-Stem Cell Interface in China -- Chapter 15: Challenges to international stem cell clinical trials in countries with diverging regulations.
У: Springer eBooksЗведення: This invaluable resource discusses the saftey, ethics, and regulations of developing stem cell clinical applications. Each chapter is contributed by a preeminent scientist in the field and covers such topics as clinical safety of stem cell gene therapy, the patentability of hESC technologies, international guidelines, challenges to international stem cell clinical trials, worldwide regulations including in emerging markets like China and Taiwan. Saftey, Ethics, and Regulations and the other books in the Stem Cells in Clinical Applications series will be invaluable to scientists, researchers, advanced students and clinicians working in stem cells, regenerative medicine or tissue engineering.
Тип одиниці: ЕКнига Списки з цим бібзаписом: Springer Ebooks (till 2020 - Open Access)+(2017 Network Access)) | Springer Ebooks (2017 Network Access))
Мітки з цієї бібліотеки: Немає міток з цієї бібліотеки для цієї назви. Ввійдіть, щоб додавати мітки.
Оцінки зірочками
    Середня оцінка: 0.0 (0 голос.)
Немає реальних примірників для цього запису

Part  I. Safety -- Chapter 1: The safety of allogeneic stem cell transplantation -- Chapter 2: Induced Pluripotent Stem Cell Therapy and Safety Concerns in Age-related Chronic Neurodegenerative Diseases -- Chapter 3: IClinical safety and applications of stem cell gene therapy -- Chapter 4:  The safety of non-expanded multipotential stromal cell therapies -- Part  II: Ethics and Regulations -- Chapter 5: A Normative Case for the Patentability of Human Embryonic Stem Cell Technologies -- Chapter 6. Ethical Considerations in Stem Cell Research on Neurologic and Orthopedic Conditions -- Chapter 7. New Regulatory Pathways for Stem Cell-Based Therapies: Comparison and Critique of Potential Models -- Chapter 8: Travelling cells – Harmonised European Regualtion and the BAMI stem cell trial -- Chapter 9: Oversight and Evidence in Stem Cell Innovation: An Examination of International Guidelines -- Chapter 10: The regulation of clinical stem cell research in China -- Chapter 11: Gov erning Stem Cell Therapies in India -- Chapter 12: Patenting human embryonic stem cells in the European Union context: an updated analysis of a complex issue -- Chapter 13: The regulatory situation for clinical stem cell research in China -- Chapter 14: Contested Tissues: the donation of oocytes and embryos in the IVF-Stem Cell Interface in China -- Chapter 15: Challenges to international stem cell clinical trials in countries with diverging regulations.

This invaluable resource discusses the saftey, ethics, and regulations of developing stem cell clinical applications. Each chapter is contributed by a preeminent scientist in the field and covers such topics as clinical safety of stem cell gene therapy, the patentability of hESC technologies, international guidelines, challenges to international stem cell clinical trials, worldwide regulations including in emerging markets like China and Taiwan. Saftey, Ethics, and Regulations and the other books in the Stem Cells in Clinical Applications series will be invaluable to scientists, researchers, advanced students and clinicians working in stem cells, regenerative medicine or tissue engineering.

Available to subscribing member institutions only. Доступно лише організаціям членам підписки.

Online access from local network of NaUOA.

Online access with authorization at https://link.springer.com/

Онлайн-доступ з локальної мережі НаУОА.

Онлайн доступ з авторизацією на https://link.springer.com/

Немає коментарів для цієї одиниці.

для можливості публікувати коментарі.